Key statistics
On Thursday, Organon & Co (OGN*:MEX) closed at 113.00, 0.00% above its 52-week low of 113.00, set on Feb 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 132.00 |
|---|---|
| High | 132.00 |
| Low | 113.00 |
| Bid | 122.01 |
| Offer | 130.99 |
| Previous close | 113.00 |
| Average volume | 85.50 |
|---|---|
| Shares outstanding | 259.98m |
| Free float | 259.32m |
| P/E (TTM) | 3.84 |
| Market cap | 1.92bn USD |
| EPS (TTM) | 1.92 USD |
| Annual div (ADY) | 1.37 MXN |
|---|---|
| Annual div yield (ADY) | 1.22% |
| Div ex-date | Nov 20 2025 |
| Div pay-date | Dec 11 2025 |
| Next div ex-date | Feb 23 2026 |
| Next div pay-date | Mar 12 2026 |
Data delayed at least 20 minutes, as of Feb 12 2026 20:59 GMT.
More ▼
Press releases
- Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
- Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
- Organon Completes Divestiture of JADA® System to Laborie
- Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
- Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
- Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
More ▼
